Skip to main content
. Author manuscript; available in PMC: 2022 Apr 13.
Published in final edited form as: J Med Chem. 2020 Oct 29;63(21):12957–12977. doi: 10.1021/acs.jmedchem.0c01398

Figure 7.

Figure 7.

In vivo target engagement and concentrations of compound 27 in an H460 NSG mouse xenograft model. Compound 27 (bis-hydrochloride) was administered orally at the indicated doses in an 0.5% aqueous methylcellulose vehicle. There were six animals per group. (a) Glutamate:glutamine ratios at 8 hours and 24 hours after each dose, with standard deviation bars; (b) Free plasma concentrations, with standard deviations, of compound 27 at 8 hours and 24 hours for each dose.